Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin for ECG changes in STEMI patients after angioplasty
IRCT20230926059531N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myocardial infarction (MI) comparing Empagliflozin with Placebo (2 arms). Primary endpoints: Better treatment of the disease, Improvement of future treatment methods and 2 more. Started Dec 2023; status: completed.
02
Drugs
empagliflozin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20230926059531N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230926059531N1.